Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
490.8 USD | +0.43% |
|
+1.86% | +20.63% |
12:55pm | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $589 From $577, Maintains Buy Rating | MT |
15/07 | Vertex Sues U.S. to Pay for Fertility Treatments | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.63% | 13TCr | |
+25.01% | 2.77TCr | |
-20.17% | 2.03TCr | |
-17.17% | 1.68TCr | |
-18.07% | 1.56TCr | |
-47.70% | 1.46TCr | |
+11.92% | 1.48TCr | |
+58.32% | 1.44TCr | |
+149.98% | 1.25TCr | |
-10.27% | 984.15Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 06